Vivos (RDGL) Net Margin Growth (3y) (2014 - 2025)
Vivos (RDGL) Net Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 300.00 |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 650,059.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 650,059.00 |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | 319,694.00 |
| Mar 31, 2025 | 226,329.00 |
| Sep 30, 2024 | -1.52 Mn |
| Sep 30, 2023 | -760,141.00 |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 410,461.00 |
| Sep 30, 2019 | -451,954.00 |
| Mar 31, 2017 | -257,151.00 |
| Sep 30, 2016 | -302,301.00 |
| Mar 31, 2016 | -14.08 Mn |
| Sep 30, 2015 | -1.74 Mn |
| Mar 31, 2015 | 1.47 Mn |
| Jun 30, 2014 | -1.18 Mn |
| Mar 31, 2014 | -720,853.00 |